Beryllium disease.
Saltini C, Amicosante M.
Am J Med Sci. 2001 Jan;321(1):89-98. doi: 10.1097/00000441-200101000-00013.
Immunologic Effects of Beryllium Exposure.
Fontenot AP.
Ann Am Thorac Soc. 2018 Apr;15(Suppl 2):S81-S85. doi: 10.1513/AnnalsATS.201707-573MG.
[Sarcoidosis and berylliosis].
Soriano D, Quartucci C, Agarwal P, Müller-Quernheim J, Frye BC.
Internist (Berl). 2022 May;63(5):557-565. doi: 10.1007/s00108-022-01323-x. Epub 2022 Apr 9.
Beryllium disease.
Jones Williams W.
Postgrad Med J. 1988 Jul;64(753):511-6. doi: 10.1136/pgmj.64.753.511.
Mechanisms of granulomatous lung disease from inhaled beryllium: the role of antigenicity in granuloma formation.
Haley PJ.
Toxicol Pathol. 1991;19(4 Pt 1):514-25. doi: 10.1177/019262339101900417.
[Beryllium granuloma].
POLICARD A.
Med Lav. 1952 Feb;43(2):66-77.
Chronic Beryllium Disease Finding Requires Reexamination.
Kolanz M, Dumas C.
Chest. 2021 Jun;159(6):2508-2509. doi: 10.1016/j.chest.2020.12.061.
[Beryllium granuloma].
Grupper C, Hincky M, Edelson Y.
Bull Soc Fr Dermatol Syphiligr. 1970;77(2):156-7.
The beryllium granuloma.
Williams WJ.
Proc R Soc Med. 1971 Sep;64(9):946-8. doi: 10.1177/003591577106400931.
Immunology of chronic beryllium disease.
Samuel G, Maier LA.
Curr Opin Allergy Clin Immunol. 2008 Apr;8(2):126-34. doi: 10.1097/ACI.0b013e3282f824a4.
